GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Cyclically Adjusted PB Ratio

Xenon Pharmaceuticals (FRA:XP0) Cyclically Adjusted PB Ratio : 12.55 (As of May. 16, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-05-16), Xenon Pharmaceuticals's current share price is €37.40. Xenon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €2.98. Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 12.55.

The historical rank and industry rank for Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:XP0' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 12.51   Med: 20.13   Max: 36.85
Current: 12.51

During the past years, Xenon Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 36.85. The lowest was 12.51. And the median was 20.13.

FRA:XP0's Cyclically Adjusted PB Ratio is ranked worse than
92.26% of 646 companies
in the Biotechnology industry
Industry Median: 1.76 vs FRA:XP0: 12.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Xenon Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was €10.823. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.98 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Xenon Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Xenon Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 29.00 15.23

Xenon Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.99 17.28 14.00 15.23 13.27

Competitive Comparison of Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Xenon Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=37.40/2.98
=12.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Xenon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.823/126.2576*126.2576
=10.823

Current CPI (Mar. 2024) = 126.2576.

Xenon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.469 99.473 1.865
201409 -3.858 99.394 -4.901
201412 4.162 98.367 5.342
201503 -5.103 99.789 -6.457
201506 -5.213 100.500 -6.549
201509 -5.211 100.421 -6.552
201512 3.895 99.947 4.920
201603 -5.647 101.054 -7.055
201606 -5.940 102.002 -7.353
201609 -5.158 101.765 -6.399
201612 3.378 101.449 4.204
201703 -6.060 102.634 -7.455
201706 -6.101 103.029 -7.477
201709 -6.085 103.345 -7.434
201712 1.687 103.345 2.061
201803 0.382 105.004 0.459
201806 1.397 105.557 1.671
201809 3.376 105.636 4.035
201812 3.262 105.399 3.908
201903 2.904 106.979 3.427
201906 2.577 107.690 3.021
201909 2.346 107.611 2.753
201912 2.694 107.769 3.156
202003 4.666 107.927 5.458
202006 4.607 108.401 5.366
202009 4.228 108.164 4.935
202012 3.841 108.559 4.467
202103 5.507 110.298 6.304
202106 5.031 111.720 5.686
202109 4.951 112.905 5.537
202112 9.295 113.774 10.315
202203 9.273 117.646 9.952
202206 11.943 120.806 12.482
202209 12.162 120.648 12.727
202212 10.882 120.964 11.358
202303 10.167 122.702 10.462
202306 9.364 124.203 9.519
202309 9.176 125.230 9.251
202312 11.290 125.072 11.397
202403 10.823 126.258 10.823

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xenon Pharmaceuticals  (FRA:XP0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Xenon Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xenon Pharmaceuticals (FRA:XP0) Business Description

Traded in Other Exchanges
Address
200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Xenon Pharmaceuticals (FRA:XP0) Headlines

No Headlines